White Paper: Psychedelics
Published March 2021
Abstract:
Psychedelics are a subset of hallucinogenic drugs that alter mood, cognitive processes, and consciousness by influencing how neurotransmitters operate at the synapses of the central nervous system. Because of their high potential for abuse, psychedelics are classified as controlled substances by a variety of regulatory agencies. However, research has shown that psychedelics, such as psilocybin, may play a role in treatments for psychiatric disorders. This white paper explores:
- What are Psychedelics?
- Types of Psychedelics
- Mechanism of Action of Psychedelics
- Global Legislation/Regulation
- The History of Psychedelics
- Psychedelic News
- Psychedelics and Ecology
Keywords: psychedelics, psilocybin, hallucinogenic drugs, controlled substances, clinical trials, mental illness, mechanism of action, Health Canada, narcotic control, FDA, EMA, TGA, psychotherapy, ecology
Click here to view White paper: Psychedelics